Co-Diagnostics, Inc. Operating Lease Cost
Co-Diagnostics, Inc. (CODX) reported Operating Lease Cost of $267.27 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- Co-Diagnostics, Inc. operating lease, cost for the quarter ending 2026-06-30 was $267.27K, a 3.54% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, cost for the quarter ending 2026-03-31 was $261.69K, a 1.40% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, cost for the quarter ending 2025-12-31 was $261.67K, a 1.61% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, cost for the quarter ending 2025-09-30 was $259.64K, a 0.58% increase year-over-year.
- Co-Diagnostics, Inc. operating lease, cost for fiscal 2025 was $1.04M, a 1.77% increase from fiscal 2024.
- Co-Diagnostics, Inc. operating lease, cost for fiscal 2024 was $1.02M, a 25.29% increase from fiscal 2023.
- Co-Diagnostics, Inc. operating lease, cost for fiscal 2023 was $813.74K, a 134.95% increase from fiscal 2022.
- Co-Diagnostics, Inc. operating lease, cost for fiscal 2022 was $346.35K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $267.27K 10-Q · filed 2026-08-13 | $528.95K 10-Q · filed 2026-08-13 | $790.62K derived: sum of 3 quarters · filed 2026-08-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $261.69K 10-Q · filed 2026-05-14 | $523.35K derived: sum of 2 quarters · filed 2026-05-14 | $783.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $261.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $521.31K derived: sum of 2 quarters · filed 2026-03-31 | $779.43K derived: sum of 3 quarters · filed 2026-08-13 | $1.04M 10-K · filed 2026-03-31 |
| 2025-09-30 | $259.64K 10-Q · filed 2025-11-13 | $517.76K derived: sum of 2 quarters · filed 2026-08-13 | $775.83K 10-Q · filed 2025-11-13 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $258.12K 10-Q · filed 2026-08-13 | $516.19K 10-Q · filed 2026-08-13 | $773.70K derived: sum of 3 quarters · filed 2026-08-13 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $258.06K 10-Q · filed 2026-05-14 | $515.58K derived: sum of 2 quarters · filed 2026-05-14 | $773.72K derived: sum of 3 quarters · filed 2026-05-14 | $1.03M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $257.51K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $515.66K derived: sum of 2 quarters · filed 2026-03-31 | $768.30K derived: sum of 3 quarters · filed 2026-03-31 | $1.02M 10-K · filed 2026-03-31 |
| 2024-09-30 | $258.14K 10-Q · filed 2025-11-13 | $510.79K derived: sum of 2 quarters · filed 2025-11-13 | $761.99K 10-Q · filed 2025-11-13 | $1.06M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $252.65K 10-Q · filed 2025-08-14 | $503.84K 10-Q · filed 2025-08-14 | $805.28K derived: sum of 3 quarters · filed 2025-08-14 | $1.05M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $267.98K 10-Q · filed 2025-05-08 | $552.64K derived: sum of 2 quarters · filed 2025-05-08 | $797.58K derived: sum of 3 quarters · filed 2025-05-08 | $860.43K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $284.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $529.60K derived: sum of 2 quarters · filed 2025-03-27 | $592.44K derived: sum of 3 quarters · filed 2025-03-27 | $813.74K 10-K · filed 2025-03-27 |
| 2023-09-30 | $244.94K 10-Q · filed 2024-11-07 | $307.79K derived: sum of 2 quarters · filed 2024-11-07 | $529.09K 10-Q · filed 2024-11-07 | $488.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $62.85K 10-Q · filed 2024-08-08 | $150.45K 10-Q · filed 2024-08-08 | $243.06K derived: sum of 3 quarters · filed 2024-08-08 | $325.85K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $87.61K 10-Q · filed 2023-05-11 | $180.21K derived: sum of 2 quarters · filed 2023-05-11 | $263.00K derived: sum of 3 quarters · filed 2023-05-11 | $347.37K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $92.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $175.40K derived: sum of 2 quarters · filed 2023-03-16 | $259.76K derived: sum of 3 quarters · filed 2023-03-16 | $346.35K 10-K · filed 2023-03-16 |
| 2022-09-30 | $82.80K 10-Q · filed 2022-11-10 | $167.16K derived: sum of 2 quarters · filed 2022-11-10 | $253.75K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $84.36K 10-Q · filed 2022-08-11 | $170.95K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $86.59K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |